Skip to content

RVMD

Revolution Medicines, Inc.

NASDAQ · Healthcare · Biotechnology · US

$203.77
+0.21%
Ask drillr
0
Insider buys (3m)
64
Insider sells (3m)
-$69.3M
Net value (3m)
+31.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 10, 2026Kim Lorence H. · directorSale2,853$210
Sep 10, 2026Kim Lorence H. · directorSale999$207
Sep 10, 2026Kim Lorence H. · directorSale706$207
Sep 10, 2026Kim Lorence H. · directorSale371$212
Sep 10, 2026Kim Lorence H. · directorSale3,844$211
Sep 10, 2026Kim Lorence H. · directorSale4,730$211
Sep 10, 2026Kim Lorence H. · directorSale3,587$209
Sep 2, 2026Kim Lorence H. · directorSale300$201
Sep 2, 2026Kim Lorence H. · directorSale6,597$201
Sep 2, 2026Kim Lorence H. · directorSale7,271$204
Sep 2, 2026Kim Lorence H. · directorSale26,160$204
Sep 2, 2026Kim Lorence H. · directorSale2,128$205
Sep 2, 2026Kim Lorence H. · directorSale625$206
Sep 2, 2026Kim Lorence H. · directorSale12,919$202
Aug 25, 2026Cislini Jeff · officer: General CounselSale2,540$210
Aug 25, 2026Cislini Jeff · officer: General CounselSale3,400$207
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale24,917$208
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale126$210
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale3,813$210
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale951$208
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale5,128$207
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale245$211
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale1,351$209
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale1,405$209
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale136$210
Aug 25, 2026Cislini Jeff · officer: General CounselSale25,817$209
Aug 25, 2026Cislini Jeff · officer: General CounselSale4,500$211
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale177$207
Aug 25, 2026GOLDSMITH MARK A · director, officer: See RemarksSale35,938$209
Aug 25, 2026Cislini Jeff · officer: General CounselM-Exempt29,680$19
Institutional positioning

13F filings over the trailing two quarters

New 419Increased 411Reduced 288Sold out 62
FilerActionSharesFiled
BlackRock, Inc.Increased13,695,790Aug 7, 2026
FARALLON CAPITAL MANAGEMENT LLCReduced13,604,796May 15, 2026
FARALLON CAPITAL MANAGEMENT LLCReduced13,550,796Aug 14, 2026
FMR LLCIncreased12,200,422Aug 13, 2026
BAKER BROS. ADVISORS LPIncreased11,443,357Aug 14, 2026
BLACKROCK, INC.Increased11,212,706May 13, 2026
Jupiter Topco LLCNew Position10,736,145Aug 14, 2026
Darwin Global Management, Ltd.Increased10,629,822Aug 14, 2026
JANUS HENDERSON GROUP PLCReduced9,766,496May 18, 2026
BAKER BROS. ADVISORS LPIncreased9,555,357May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased9,088,661Aug 13, 2026
FMR LLCReduced8,464,314May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position8,362,284May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased8,294,855Aug 13, 2026
NEXTECH INVEST, LTD.Unchanged7,601,087May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 10, 2026